Literature DB >> 25044936

The homeodomain transcription factor PITX2 is required for specifying correct cell fates and establishing angiogenic privilege in the developing cornea.

Philip J Gage1, Chen Kuang, Amanda L Zacharias.   

Abstract

BACKGROUND: Correct specification of cell lineages and establishing angiogenic privilege within the developing cornea are essential for normal vision but the mechanisms controlling these processes are poorly understood.
RESULTS: We show that the homeodomain transcription factor PItX2 is expressed in mesenchymal cells of the developing and mature cornea and use a temporal gene knockout approach to demonstrate that PITX2 is required for corneal morphogenesis and the specification of cell fates within the surface ectoderm and mesenchymal primordia. PITX2 is also required to establish angiogenic privilege in the developing cornea. Further, the expression of Dkk2 and suppression of canonical Wnt signaling activity levels are key mechanisms by which PITX2 specifies ocular surface ectoderm as cornea. In contrast, specifying the underlying mesenchyme to corneal fates and establishing angiogenic privilege in the cornea are less sensitive to DKK2 activity. Finally, the cellular expression patterns of FOXC2, PITX1, and BARX2 in Pitx2 and Dkk2 mutants suggest that these transcription factors may be involved in specifying cell fate and establishing angiogenic privilege within the corneal mesenchyme. However, they are unlikely to play a role in specifying cell fate within the corneal ectoderm.
CONCLUSIONS: Together, these data provide important insights into the mechanisms regulating cornea development.
Copyright © 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Dkk2; canonical Wnt signaling; glaucoma; ocular anterior segment; temporal gene knockout

Mesh:

Substances:

Year:  2014        PMID: 25044936      PMCID: PMC4206698          DOI: 10.1002/dvdy.24165

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  31 in total

1.  A large-scale in situ screen provides molecular evidence for the induction of eye anterior segment structures by the developing lens.

Authors:  C J Thut; R B Rountree; M Hwa; D M Kingsley
Journal:  Dev Biol       Date:  2001-03-01       Impact factor: 3.582

Review 2.  Early eye development in vertebrates.

Authors:  R L Chow; R A Lang
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

3.  Persistent Prop1 expression delays gonadotrope differentiation and enhances pituitary tumor susceptibility.

Authors:  L J Cushman; D E Watkins-Chow; M L Brinkmeier; L T Raetzman; A L Radak; R V Lloyd; S A Camper
Journal:  Hum Mol Genet       Date:  2001-05-15       Impact factor: 6.150

4.  TGFbeta2 in corneal morphogenesis during mouse embryonic development.

Authors:  S Saika; S Saika; C Y Liu; M Azhar; L P Sanford; T Doetschman; R L Gendron; C W Kao; W W Kao
Journal:  Dev Biol       Date:  2001-12-15       Impact factor: 3.582

5.  LMX1B, a LIM homeodomain class transcription factor, is necessary for normal development of multiple tissues in the anterior segment of the murine eye.

Authors:  C L Pressman; H Chen; R L Johnson
Journal:  Genesis       Date:  2000-01       Impact factor: 2.487

6.  Pitx2 distinguishes subtypes of terminally differentiated neurons in the developing mouse neuroepithelium.

Authors:  Donna M Martin; Jennifer M Skidmore; Sharon E Fox; Philip J Gage; Sally A Camper
Journal:  Dev Biol       Date:  2002-12-01       Impact factor: 3.582

7.  Characterization of Wnt signaling components and activation of the Wnt canonical pathway in the murine retina.

Authors:  Hong Liu; Othman Mohamed; Daniel Dufort; Valerie A Wallace
Journal:  Dev Dyn       Date:  2003-07       Impact factor: 3.780

8.  BMP signaling is required for development of the ciliary body.

Authors:  Shulei Zhao; Qin Chen; Fang-Cheng Hung; Paul A Overbeek
Journal:  Development       Date:  2002-10       Impact factor: 6.868

9.  Pitx2 is required at multiple stages of pituitary organogenesis: pituitary primordium formation and cell specification.

Authors:  Hoonkyo Suh; Philip J Gage; Jacques Drouin; Sally A Camper
Journal:  Development       Date:  2002-01       Impact factor: 6.868

10.  Chromosomal duplication involving the forkhead transcription factor gene FOXC1 causes iris hypoplasia and glaucoma.

Authors:  O J Lehmann; N D Ebenezer; T Jordan; M Fox; L Ocaka; A Payne; B P Leroy; B J Clark; R A Hitchings; S Povey; P T Khaw; S S Bhattacharya
Journal:  Am J Hum Genet       Date:  2000-09-27       Impact factor: 11.043

View more
  16 in total

1.  Generation and validation of a PITX2-EGFP reporter line of human induced pluripotent stem cells enables isolation of periocular mesenchymal cells.

Authors:  Toru Okubo; Ryuhei Hayashi; Shun Shibata; Yuji Kudo; Yuki Ishikawa; Saki Inoue; Yuki Kobayashi; Ai Honda; Yoichi Honma; Satoshi Kawasaki; Kohji Nishida
Journal:  J Biol Chem       Date:  2020-02-07       Impact factor: 5.157

2.  Transcriptomic analysis of differential gene expression during chick periocular neural crest differentiation into corneal cells.

Authors:  Lian Bi; Peter Lwigale
Journal:  Dev Dyn       Date:  2019-05-02       Impact factor: 3.780

Review 3.  Induced Pluripotent Stem Cell-Derived Corneal Cells: Current Status and Application.

Authors:  Nasif Mahmood; Taylor Cook Suh; Kiran M Ali; Eelya Sefat; Ummay Mowshome Jahan; Yihan Huang; Brian C Gilger; Jessica M Gluck
Journal:  Stem Cell Rev Rep       Date:  2022-08-01       Impact factor: 6.692

Review 4.  Limbal stem cells: identity, developmental origin, and therapeutic potential.

Authors:  Gabriel Gonzalez; Yuzuru Sasamoto; Bruce R Ksander; Markus H Frank; Natasha Y Frank
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2017-11-03       Impact factor: 5.814

5.  H3K4me1 marks DNA regions hypomethylated during aging in human stem and differentiated cells.

Authors:  Agustín F Fernández; Gustavo F Bayón; Rocío G Urdinguio; Estela G Toraño; María G García; Antonella Carella; Sandra Petrus-Reurer; Cecilia Ferrero; Pablo Martinez-Camblor; Isabel Cubillo; Javier García-Castro; Jesús Delgado-Calle; Flor M Pérez-Campo; José A Riancho; Clara Bueno; Pablo Menéndez; Anouk Mentink; Katia Mareschi; Fabian Claire; Corrado Fagnani; Emanuela Medda; Virgilia Toccaceli; Sonia Brescianini; Sebastián Moran; Manel Esteller; Alexandra Stolzing; Jan de Boer; Lorenza Nisticò; Maria A Stazi; Mario F Fraga
Journal:  Genome Res       Date:  2014-09-30       Impact factor: 9.043

6.  AP-2β Is a Downstream Effector of PITX2 Required to Specify Endothelium and Establish Angiogenic Privilege During Corneal Development.

Authors:  Lisheng Chen; Vanessa Martino; Alan Dombkowski; Trevor Williams; Judith West-Mays; Philip J Gage
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-03       Impact factor: 4.799

7.  Conditional deletion of AP-2β in mouse cranial neural crest results in anterior segment dysgenesis and early-onset glaucoma.

Authors:  Vanessa B Martino; Thomas Sabljic; Paula Deschamps; Rebecca M Green; Monica Akula; Erica Peacock; Alexander Ball; Trevor Williams; Judith A West-Mays
Journal:  Dis Model Mech       Date:  2016-06-23       Impact factor: 5.758

8.  Foxc1 and Foxc2 in the Neural Crest Are Required for Ocular Anterior Segment Development.

Authors:  Seungwoon Seo; Lisheng Chen; Wenzhong Liu; Demin Zhao; Kathryn M Schultz; Amy Sasman; Ting Liu; Hao F Zhang; Philip J Gage; Tsutomu Kume
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-03-01       Impact factor: 4.799

9.  Heterozygous Pitx2 Null Mice Accurately Recapitulate the Ocular Features of Axenfeld-Rieger Syndrome and Congenital Glaucoma.

Authors:  Lisheng Chen; Philip J Gage
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-09-01       Impact factor: 4.799

10.  Restricted Presence of POU6F2 in Human Corneal Endothelial Cells Uncovered by Extension of the Promoter-level Expression Atlas.

Authors:  Masahito Yoshihara; Susumu Hara; Motokazu Tsujikawa; Satoshi Kawasaki; Yoshihide Hayashizaki; Masayoshi Itoh; Hideya Kawaji; Kohji Nishida
Journal:  EBioMedicine       Date:  2017-11-04       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.